Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Myeloid Cancer
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing
so they stop growing or die. Combining monoclonal antibody therapy with chemotherapy may kill
more cancer cells.
PURPOSE: Phase I/II trial to study the effectiveness of combining chemotherapy and monoclonal
antibody therapy in treating patients who have advanced myeloid cancer.